Drug Information

Drug General Information
Drug ID
D0J3XJ
Former ID
DNC009563
Drug Name
N-(3-Phenyl)propyl-2-(4-bromophenylacetamide)
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529563]
Formula
C23H22BrNO
PubChem Compound ID
44578696
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [529563]
Cannabinoid receptor 2 Target Info Inhibitor [529563]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signalinghsa04080:Neuroactive ligand-receptor interaction
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like
References
Ref 529563Bioorg Med Chem. 2008 Aug 1;16(15):7510-5. Epub 2008 Jun 7.Novel sterically hindered cannabinoid CB1 receptor ligands.
Ref 529563Bioorg Med Chem. 2008 Aug 1;16(15):7510-5. Epub 2008 Jun 7.Novel sterically hindered cannabinoid CB1 receptor ligands.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.